Year: 2008

Anil Ambani has finally made it public about his IT Consulting ambitions. Fueled with synergies from RCom + Yipes, Anil Ambani has hand picked a team of 15 professionals to scale the IT business.

The company will operate in the domains of consultancy, infrastructure management, application development, management and domestic SME market.

With falling dollar and margins under heavy pressure, Sr executives at Infosys, TCS and Satyam are already looking towards Anil Ambani’s Tech Reliance to make their last Stock Options bounty. Hyderabad, Kolkata, Mumbai and Gurgaon IT centers will open for business within the next 6 weeks.

Venus Remedies has been accredited with the European GMP certification for its cephalosporin and carbapenem plants at Baddi, India, a rare and most coveted certification for regulated markets.
The cephalosporin and carbapenem plants of the company were inspected by the European authorities and found to be complying with the manufacturing and quality control standards as per the European good manufacturing practice.

The European – GMP certification is a pre-requisite for Export to European union. Venus is the only company in India to have an EU-GMP certified plant for carbapenems, which the have huge market potential across the globe. With this accreditation, the company can now freely export to not only 36 countries of European union, but also to Canada and Australia, which recognize European GMP. Now the company can surge ahead in the regulated European and Canadian markets, as per its strategy, in sync with its subsidiary Venus Pharma GmbH, Germany and realize its export targets as per projections.

The board of Marksans Pharma has decided to enter into share purchase agreement with Hale Group, U.K. for acquiring its entire share capital along with its subsidiary company Bell, Sons & Co. (Druggists) and authority to Mark Saldanha, managing director to execute the same. The above acquisition shall be through companies 100% subsidiary, Marksans Pharma U.K.